AtheroNova

AtheroNova Inc. is a clinical-stage biotechnology company focused on the discovery, research, development, and licensing of novel compounds to reduce atherosclerotic plaque deposits. The company concentrates on compounds that reduce or eliminate atherosclerotic plaque deposits for the treatment and prevention of cardiovascular diseases.